Boston Trust Walden Corp Sells 7,746 Shares of U.S. Physical Therapy, Inc. $USPH

Boston Trust Walden Corp decreased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 490,068 shares of the company’s stock after selling 7,746 shares during the period. Boston Trust Walden Corp owned approximately 3.22% of U.S. Physical Therapy worth $41,631,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Parallel Advisors LLC lifted its stake in shares of U.S. Physical Therapy by 90.6% in the 2nd quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after purchasing an additional 213 shares during the period. Cullen Frost Bankers Inc. grew its stake in U.S. Physical Therapy by 171.8% during the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock worth $35,000 after purchasing an additional 280 shares during the period. Assetmark Inc. increased its holdings in U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after purchasing an additional 150 shares in the last quarter. Huntington National Bank increased its holdings in U.S. Physical Therapy by 71.9% in the second quarter. Huntington National Bank now owns 667 shares of the company’s stock worth $52,000 after purchasing an additional 279 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in U.S. Physical Therapy by 35.3% in the third quarter. Blue Trust Inc. now owns 640 shares of the company’s stock valued at $54,000 after buying an additional 167 shares during the period.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on USPH shares. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, November 24th. Barrington Research reissued an “outperform” rating and set a $103.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, October 24th. Finally, Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Four equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $105.33.

U.S. Physical Therapy Stock Performance

USPH opened at $81.49 on Tuesday. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $93.50. The company has a market cap of $1.24 billion, a price-to-earnings ratio of 34.24, a PEG ratio of 3.76 and a beta of 1.32. The company’s fifty day moving average price is $78.81 and its two-hundred day moving average price is $80.31. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a net margin of 5.71% and a return on equity of 8.62%. The company had revenue of $140.66 million during the quarter. On average, analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Monday, November 17th were paid a $0.45 dividend. The ex-dividend date was Monday, November 17th. This represents a $1.80 annualized dividend and a yield of 2.2%. U.S. Physical Therapy’s dividend payout ratio is presently 75.63%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.